{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:42:41Z","timestamp":1787884961379,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005147","name":"Yunnan Applied Basic Research Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011238","name":"State Key Laboratory of Phytochemistry and Plant Resources in West China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013102","name":"Shanghai City Youth Science and Technology Star Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018531","name":"Major Science and Technology Projects in Yunnan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018531","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bioorg.2025.108147","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T18:08:59Z","timestamp":1736359739000},"page":"108147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Design, synthesis and activity evaluation of novel quinazolinone compounds as TRPC5 inhibitors"],"prefix":"10.1016","volume":"155","author":[{"given":"Longhui","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.bioorg.2025.108147_b0005","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1021\/acs.jmedchem.8b01954","article-title":"Review of transient receptor potential canonical (TRPC5) channel modulators and diseases","volume":"62","author":"Sharma","year":"2019","journal-title":"J. Med. Chem."},{"issue":"38","key":"10.1016\/j.bioorg.2025.108147_b0010","doi-asserted-by":"crossref","first-page":"33436","DOI":"10.1074\/jbc.M111.274167","article-title":"Identification of ML204, a novel potent antagonist that selectively modulates native TRPC4\/C5 ion channels","volume":"286","author":"Miller","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108147_b0015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1681\/ASN.2017060682","article-title":"TRPC5 does not cause or aggravate glomerular disease","volume":"29","author":"Wang","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108147_b0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1097-2765(02)00448-3","article-title":"A unified nomenclature for the superfamily of TRP cation channels","volume":"9","author":"Montell","year":"2002","journal-title":"Mol. Cell"},{"issue":"1\u20133","key":"10.1016\/j.bioorg.2025.108147_b0025","first-page":"21","article-title":"The mammalian TRPC cation channels","volume":"1742","author":"Vazquez","year":"2004","journal-title":"BBA"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108147_b0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/35077544","article-title":"The TRP ion channel family","volume":"2","author":"Clapham","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108147_b0035","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/01.RES.88.3.325","article-title":"The transient receptor potential protein homologue TRP6 is the essential component of vascular alpha(1)-adrenoceptor-activated Ca(2+)-permeable cation channel","volume":"88","author":"Inoue","year":"2001","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108147_b0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neulet.2007.05.042","article-title":"Immunohistochemical study on the distribution of canonical transient receptor potential channels in rat basal ganglia","volume":"422","author":"Chung","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bioorg.2025.108147_b0045","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.63429","article-title":"Structural basis for human TRPC5 channel inhibition by two distinct inhibitors","volume":"10","author":"Song","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.bioorg.2025.108147_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2021.102414","article-title":"A greasy business: Identification of a diacylglycerol binding site in human TRPC5 channels by cryo-EM","volume":"97","author":"Storch","year":"2021","journal-title":"Cell Calcium"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108147_b0055","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1124\/mol.114.093229","article-title":"Clemizole hydrochloride is a novel and potent inhibitor of transient receptor potential channel TRPC5","volume":"86","author":"Richter","year":"2014","journal-title":"Mol. Pharmacol."},{"issue":"20","key":"10.1016\/j.bioorg.2025.108147_b0060","doi-asserted-by":"crossref","first-page":"8158","DOI":"10.1074\/jbc.M116.773556","article-title":"Picomolar, selective, and subtype-specific small-molecule inhibition of TRPC1\/4\/5 channels","volume":"292","author":"Rubaiy","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.108147_b0065","doi-asserted-by":"crossref","unstructured":"Y. Zhou, P. Castonguay, E.H. Sidhom, A.R. Clark, M. Dvela-Levitt, S. Kim, J. Sieber, N. Wieder, J.Y. Jung, S. Andreeva, J. Reichardt, F. Dubois, S.C. Hoffmann, J.M. Basgen, M.S. Montesinos, A. Weins, A.C. Johnson, E.S. Lander, M.R. Garrett, C.R. Hopkins, A. Greka, A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models, Science (New York, N.Y.). 358(6368) (2017) 1332\u20131336, http:\/\/doi.org\/10.1126\/science.aal4178.","DOI":"10.1126\/science.aal4178"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108147_b0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bmcl.2018.12.007","article-title":"Design, synthesis and characterization of novel N-heterocyclic-1-benzyl-1H-benzo[d]imidazole-2-amines as selective TRPC5 inhibitors leading to the identification of the selective compound, AC1903","volume":"29","author":"Sharma","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108147_b0075","doi-asserted-by":"crossref","unstructured":"A. Riccio, Y. Li, J. Moon, K.S. Kim, K.S. Smith, U. Rudolph, S. Gapon, G.L. Yao, E. Tsvetkov, S.J. Rodig, A. Van't Veer, E.G. Meloni, W.A. Carlezon, Jr., V.Y. Bolshakov, D.E. Clapham, Essential role for TRPC5 in amygdala function and fear-related behavior, Cell. 137(4) (2009) 761-72, http:\/\/doi.org\/10.1016\/j.cell.2009.03.039.","DOI":"10.1016\/j.cell.2009.03.039"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108147_b0080","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1523\/JNEUROSCI.2274-13.2014","article-title":"Decreased anxiety-like behavior and G\u03b1q\/11-dependent responses in the amygdala of mice lacking TRPC4 channels","volume":"34","author":"Riccio","year":"2014","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108147_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191225","article-title":"Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice","volume":"13","author":"Just","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108147_b0090","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/hipo.20807","article-title":"Plasma membrane insertion of TRPC5 channels contributes to the cholinergic plateau potential in hippocampal CA1 pyramidal neurons","volume":"21","author":"Tai","year":"2011","journal-title":"Hippocampus"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108147_b0095","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1073\/pnas.1522294113","article-title":"Critical roles of Gi\/o proteins and phospholipase C-\u03b41 in the activation of receptor-operated TRPC4 channels","volume":"113","author":"Thakur","year":"2016","journal-title":"PNAS"},{"key":"10.1016\/j.bioorg.2025.108147_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116853","article-title":"Synthesis of AC1903 analogs as potent transient receptor potential canonical channel 4\/5 inhibitors and biological evaluation","volume":"68","author":"Chen","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108147_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128612","article-title":"Discovery of pyrroledione analogs as potent transient receptor potential canonical channel 5 inhibitors","volume":"61","author":"Zhang","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108147_b0110","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1172\/JCI71165","article-title":"Inhibition of the TRPC5 ion channel protects the kidney filter","volume":"123","author":"Schaldecker","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bioorg.2025.108147_b0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neuroscience.2013.12.043","article-title":"A rat knockout model implicates TRPC4 in visceral pain sensation","volume":"262","author":"Westlund","year":"2014","journal-title":"Neuroscience"},{"issue":"14","key":"10.1016\/j.bioorg.2025.108147_b0120","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1111\/bph.13140","article-title":"Identification and optimization of 2-aminobenzimidazole derivatives as novel inhibitors of TRPC4 and TRPC5 channels","volume":"172","author":"Zhu","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108147_b0125","first-page":"157","article-title":"Clemizole hydrochloride: a clinical evaluation of its antipruritic effect","volume":"1","author":"Wansker","year":"1962","journal-title":"Skin"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108147_b0130","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/bph.13387","article-title":"Natural and synthetic flavonoid modulation of TRPC5 channels","volume":"173","author":"Naylor","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108147_b0135","doi-asserted-by":"crossref","unstructured":"M. Yu, M.W. Ledeboer, M. Daniels, G. Malojcic, T.T. Tibbitts, M. Coeffet-Le Gal, X.R. Pan-Zhou, A. Westerling-Bui, M. Beconi, J.F. Reilly, P. Mundel, J.C. Harmange, Discovery of a potent and selective TRPC5 inhibitor, efficacious in a focal segmental glomerulosclerosis model, ACS Med. Chem. Lett. 10(11) (2019) 1579-1585, http:\/\/doi.org\/10.1021\/acsmedchemlett.9b00430.","DOI":"10.1021\/acsmedchemlett.9b00430"},{"issue":"33","key":"10.1016\/j.bioorg.2025.108147_b0140","doi-asserted-by":"crossref","first-page":"13525","DOI":"10.1073\/pnas.0705924104","article-title":"TRPA1 mediates formalin-induced pain","volume":"104","author":"McNamara","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.bioorg.2025.108147_b0145","doi-asserted-by":"crossref","unstructured":"H.N. Rubaiy, M.J. Ludlow, R.S. Bon, D.J. Beech, Pico145 - powerful new tool for TRPC1\/4\/5 channels, Channels (Austin, Tex.). 11(5) (2017) 362-364, http:\/\/doi.org\/10.1080\/19336950.2017.1317485.","DOI":"10.1080\/19336950.2017.1317485"},{"key":"10.1016\/j.bioorg.2025.108147_b0150","unstructured":"H. Lin, L. Yan, L. Penghua, G. Li, Y. Xiaodan, C. Yijian, Z. Zhili, Discovery of potential novel TRPC 4 inhibitor by combination of virtual screening and 3D-QSAR modeling, J. South-Central Univ. Nationalities(Natural Science Edition). 2018:61-66, https:\/\/doi.org\/10.12130\/znmdzk.20180413."},{"issue":"10","key":"10.1016\/j.bioorg.2025.108147_b0155","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/1062936X.2023.2261842","article-title":"Assessing structural insights into in-house arylsulfonyl L-(+) glutamine MMP-2 inhibitors as promising anticancer agents through structure-based computational modelling approaches","volume":"34","author":"Baidya","year":"2023","journal-title":"SAR QSAR Environ. Res."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108147_b0160","doi-asserted-by":"crossref","first-page":"-","DOI":"10.2174\/1570180813666160916153017","article-title":"Possible binding mode analysis of pyrazolo-triazole hybrids as potential anticancer agents through validated molecular docking and 3D-QSAR modeling approaches","volume":"14","author":"Amin","year":"2017","journal-title":"Lett. Drug Des. Discovery"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825000276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825000276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:47:15Z","timestamp":1740358035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825000276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":32,"alternative-id":["S0045206825000276"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108147","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and activity evaluation of novel quinazolinone compounds as TRPC5 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108147"}}